Anthony D. Bruno - 10 Aug 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, attorney-in-fact for Anthony Bruno
Issuer symbol
VYNE
Transactions as of
10 Aug 2022
Net transactions value
$0
Form type
4
Filing time
12 Aug 2022, 17:11:21 UTC
Previous filing
20 Jul 2021
Next filing
15 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYNE Stock Options Award $0 +20,500 $0.000000 20,500 10 Aug 2022 Common Stock 20,500 $0.3120 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023.